Skip to content
Prosensa logo — Pioneering RNA-based therapeutic solutions for genetic disor...

Prosensa

Pioneering RNA-based therapeutic solutions for genetic disorders, anti-infectives, and oncology by leveraging strong IP and strategic outsourcing.

Founded 2002 Grant Total: $59.20M Biotechnology, Health Care

General Information

Company Name Prosensa
Founded Year 2002
Industries Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Prosensa. To contact Prosensa, visit prosensa.eu.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Prosensa compare?

A PDF of Prosensa and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Prosensa soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Prosensa

Prosensa is a pioneering biotech company committed to developing RNA-based therapeutics for genetic disorders, anti-infectives, and oncology. Formerly known as Ribpharm Inc, the company has been in operation since 2002. Prosensa's strong intellectual property portfolio and strategic approach to outsourcing set the stage for innovative, commercially appealing products. Its focus on leveraging market opportunities and outsourcing activities to specialized organizations reflects a deliberate strategy to maximize the commercial potential of its current program. The most recent injection of funding came in the form of a $200.00K grant investment from Parent Project Muscular Dystrophy on 02 July 2014. The company's dedication to RNA-based therapeutics highlights its potential for making a significant impact in the biotechnology and health care industries.

Business keywords: RNA-based therapeutics, biotech company, genetic disorders, anti-infectives, oncology, commercialization, IP portfolio, strategic outsourcing, healthcare market, commercial potential, novel products, specialized organizations, innovation, technology development

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $200.00K 1
Parent Project Muscular Dystrophy
02 Jul 2014
Venture Round €23.00M 7
New Enterprise Associates, IDInvest Partners +5
25 Jan 2012
Series B €18.00M 2
IDInvest Partners, GIMV
17 Dec 2008
Venture Round Undisclosed -
01 Dec 2008
Series A $18.00M -
01 Feb 2007

Prosensa Alternatives & Competitors

View All Alternatives
Prosensa vs
AIRNA
AIRNA United States

The next generation of RNA editing therapeutics

Series B
84 employees
Biotechnology, Health Care
Prosensa vs
Sania Therapeutics
Sania Therapeutics United Kingdom

Precision genetic neuromodulation for neural circuit dysfunction

Seed
22 employees
Biotechnology, Health Care
Prosensa vs
ArrePath
ArrePath United States

Deciphering biology, discovering new classes of anti-infectives.

Seed
16 employees
Biotechnology, Health Care

FAQ About Prosensa

Pioneering RNA-based therapeutic solutions for genetic disorders, anti-infectives, and oncology by leveraging strong IP and strategic outsourcing.
Prosensa was founded in 2002.
Prosensa operates in Biotechnology and Health Care. Its work centres on RNA-based therapeutics, biotech company, genetic disorders and anti-infectives.
Prosensa has completed 5 funding rounds, raising a total of $59.20M. The latest funding stage is Grant.
Top alternatives and competitors to Prosensa include AIRNA, Sania Therapeutics, ArrePath, Spectrum Pharmaceuticals, CV6 Therapeutics, (NI) Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Prosensa and AIRNA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Prosensa, https://bouncewatch.com/company/prosensa, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout